Mor M - Search Results

1

The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.

Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D. Russo R, et al. Among authors: mor m. J Pharmacol Exp Ther. 2007 Jul;322(1):236-42. doi: 10.1124/jpet.107.119941. Epub 2007 Apr 5. J Pharmacol Exp Ther. 2007. PMID: 17412883

2

2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.

Spadoni G, Balsamini C, Bedini A, Diamantini G, Di Giacomo B, Tontini A, Tarzia G, Mor M, Plazzi PV, Rivara S, Nonno R, Pannacci M, Lucini V, Fraschini F, Stankov BM. Spadoni G, et al. Among authors: mor m. J Med Chem. 1998 Sep 10;41(19):3624-34. doi: 10.1021/jm970721h. J Med Chem. 1998. PMID: 9733487

3

Melatonin.

Mor M, Plazzi PV, Spadoni G, Tarzia G. Mor M, et al. Curr Med Chem. 1999 Jun;6(6):501-18. Curr Med Chem. 1999. PMID: 10213796 Review.

4

Design and synthesis of melatonin receptors agonists and antagonists.

Tarzia G, Diamantini G, Mor M, Spadoni G. Tarzia G, et al. Among authors: mor m. Farmaco. 2000 Mar;55(3):184-7. doi: 10.1016/s0014-827x(00)00017-3. Farmaco. 2000. PMID: 10919077 Review.

5

2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.

Spadoni G, Balsamini C, Diamantini G, Tontini A, Tarzia G, Mor M, Rivara S, Plazzi PV, Nonno R, Lucini V, Pannacci M, Fraschini F, Stankov BM. Spadoni G, et al. Among authors: mor m. J Med Chem. 2001 Aug 30;44(18):2900-12. doi: 10.1021/jm001125h. J Med Chem. 2001. PMID: 11520198

6

Modulation of anxiety through blockade of anandamide hydrolysis.

Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D. Kathuria S, et al. Among authors: mor m. Nat Med. 2003 Jan;9(1):76-81. doi: 10.1038/nm803. Epub 2002 Dec 2. Nat Med. 2003. PMID: 12461523

7

Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.

Rivara S, Mor M, Silva C, Zuliani V, Vacondio F, Spadoni G, Bedini A, Tarzia G, Lucini V, Pannacci M, Fraschini F, Plazzi PV. Rivara S, et al. Among authors: mor m. J Med Chem. 2003 Apr 10;46(8):1429-39. doi: 10.1021/jm020982d. J Med Chem. 2003. PMID: 12672242

8

Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.

Tarzia G, Duranti A, Tontini A, Piersanti G, Mor M, Rivara S, Plazzi PV, Park C, Kathuria S, Piomelli D. Tarzia G, et al. Among authors: mor m. J Med Chem. 2003 Jun 5;46(12):2352-60. doi: 10.1021/jm021119g. J Med Chem. 2003. PMID: 12773040 Free article.

9

Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists.

Tarzia G, Duranti A, Tontini A, Spadoni G, Mor M, Rivara S, Vincenzo Plazzi P, Kathuria S, Piomelli D. Tarzia G, et al. Among authors: mor m. Bioorg Med Chem. 2003 Sep 1;11(18):3965-73. doi: 10.1016/s0968-0896(03)00413-9. Bioorg Med Chem. 2003. PMID: 12927857

10

Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities.

Mor M, Silva C, Vacondio F, Plazzi PV, Bertoni S, Spadoni G, Diamantini G, Bedini A, Tarzia G, Zusso M, Franceschini D, Giusti P. Mor M, et al. J Pineal Res. 2004 Mar;36(2):95-102. doi: 10.1046/j.1600-079x.2003.00102.x. J Pineal Res. 2004. PMID: 14962060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters